1 results match your criteria: "Vall Hebron Research Institute University Hospital[Affiliation]"
MicroRNAs as prognostic markers in ovarian cancer.
Mol Cell Endocrinol
June 2014
Research Unit in Biomedicine and Translational Oncology, Vall Hebron Research Institute University Hospital, Barcelona, Spain.
Ovarian cancer (OC) is the most lethal gynecological malignancy among women. Over 70% of women with OC are diagnosed in advanced stages and most of these cases are incurable. Although most patients respond well to primary chemotherapy, tumors become resistant to treatment.
View Article and Find Full Text PDF